Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp145 | Cancer and bone: basic, translational and clinical | ECTS2013

Synergistic anti-tumour effects on human breast cancer cells by mevalonate pathway inhibitors atorvastatin and zoledronic acid

Gobel Andy , Thiele Stefanie , Rauner Martina , Lorenz C Hofbauer , Tilman D Rachner

Introduction: Bone metastases represent a frequent complication of breast cancer and are characterized by increased tumour-driven activation of osteoclasts and subsequent bone loss. Aminobisphosphonates inhibit osteoclast function and are established therapies of skeletal metastases. Similar to statins, they block the mevalonate pathway and are thought to have direct anti-tumour effects. Here, we report on the anti-tumour potential of a sequential inhibition of the mevalonate ...

ba0001pp199 | Cell biology: osteoblasts and bone formation | ECTS2013

Effect of β-cryptoxanthin on the differentiation of human bone-marrow stromal stem-cells treated with pioglitazone

Casado-Diaz Antonio , Santiago-Mora Raquel , Dorado Gabriel , Quesada-Gomez Jose Manuel

Pioglitazone is a drug of the thiazolidinedione (TZD) class used to treat type 2 diabetes mellitus. TZD is an agonist of peroxisome proliferator-activated receptor γ (PPAR-γ) that improves insulin sensitivity, glucose and lipid metabolism and inflammation. However, TZD induces bone marrow adiposity with suppression of osteogenesis, that could contribute to bone loss and osteoporotic fractures. β-Cryptoxanthin is a carotenoid with antioxidant properties abundant ...

ba0002p86 | (1) | ICCBH2013

Assessing bone quality and fracture resistance in children using microindentation

Forestier-Zhang Lydia , Grabowski Peter , Gallagher Orla , Patel Ameeta , Madan Sanjeev , Arundel Paul , Bishop Nick

Background: At present, clinical assessment of bone strength in children predominantly relies bone mass measurement using absorptiometry (DXA) or QCT densitometric approaches. However, bone strength is not only dependent on mass/density, but also structural and material mechanical properties. Currently no technique measures bone mechanical properties. Recently, a new micro-indentation device, the reference point indentation (RPI) instrument has been validated for the measure o...

ba0003pp31 | Bone biomechanics and quality | ECTS2014

Excessive intake of soy milk affects bone development

Martins Oliveira Bruna Rezende Silva , de Carvalho Apolinario Coelho Juliana , Medeiros Ronaldo Anderson , Louzada Mario Jefferson Quirino

The purpose of this study was to analyze the influence of diet supplemented with hydrosoluble soy extract – HSE in bone mass of male and healthy Wistar rats. Sixteen (16) 30 days old animals were kept in controlled conditions with light/dark cicle and fed with commercial food and filtered water. Randomized into two groups: control group received 500 ml of water and 300 g of food, daily; supplemented group S, in addition of water and food, they also received 500 ml of soy ...

ba0004p166 | (1) | ICCBH2015

The role of AMPK pathway in mediating the effects of metformin on mesenchymal stem cell differentiation

Chen Suet Ching , Brooks Rebecca , Ahmed Syed Faisal , Yarwood Stephen J

Introduction: Insulin sensitising agents are reported to have a diverse range of effects on bone with metformin exerting positive effects and thiazolidinenediones (TZDs) exerting negative effects. 5’AMP-activated protein kinase (AMPK) plays a critical role in cellular energy homeostasis. It is widely expressed in the body and can be activated by metformin.Objective:: We investigated the role of AMPK pathway in mediating the effects of metformin on t...

ba0005p204 | Cell biology: osteoclasts and bone resorption | ECTS2016

Fluoride modulates formation and function of bone marrow macrophage-derived osteoclasts in a strain-specific manner

de Oliveira Flavia Amadeu , Amaral Pereira Amanda , da Silva Ventura Talita , Rabelo Buzalaf Marilia Afonso , de Oliveira Rodrigo Cardoso , Peres-Buzalaf Camila

Osteoclast presents a central role in several inflammatory diseases that are associated to bone destruction. This condition results from increased osteoclastic bone resorption and/or decreased bone formation. Fluoride (F) is widely consumed in the drinking water due to its anticariogenic effect and has been shown to modulate in vivo bone metabolism in a strain-specific dependent manner. It enhances bone formation in 129P3/J mice but not in A/J mice. However, its effec...

ba0005p356 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

The added value to FRAX of gait speed and tests of postural balance

Lundin Hans , Saaf Maria , Strender Lars-Erik , Salminen Helena

Objectives: Postural balance and gait speed are risk factors for falls and hip fractures independent of bone mineral density (BMD). The standard risk assessment tool, FRAX, does however not include any estimate of fall risk. Identifying high-risk individuals correctly is be of great clinical importance why further improvement of FRAX would be clinically valuable. The primary aim of this study was to see if one-leg standing time, the maximum number of steps on a line or gait sp...

ba0005p483 | Paediatric bone disease | ECTS2016

Loss of type I collagen telopeptide lysyl hydroxylation causes musculoskeletal abnormalities in a zebrafish model of Bruck syndrome

Willaert Andy , Ghistelinck Charlotte , Witten P Eckhard , Huysseune Ann , Simoens Pascal , Symoens Sofie , Malfait Fransiska , De Muynck Amelie , De Paepe Anne , Kwon Ronald Y , Weiss Mary Ann , Eyre David E , Coucke Paul

Bruck syndrome, a disorder caused by bi-allelic mutations in either PLOD2 or FKBP10, is characterized by flexion contractures and bone fractures and shows strong clinical overlap with the brittle bone disease Osteogenesis Imperfecta. PLOD2 encodes the Lysyl hydroxylase 2 (LH2) enzyme, which is responsible for the hydroxylation of lysine residues in the type-I collagen telopeptides. This hydroxylation directs cross-linking of the collagen fibrils in t...

ba0006p171 | (1) | ICCBH2017

Review of lower limb range of movement following intramedullary fixation in children with Osteogensis Imperfecta

Marr Caroline

Osteogenesis Imperfecta (OI) is a genetic condition which alters collagen biosynthesis(1). Prevalence is estimated at 1 in every 15, 000 births. It is a disorder with a wide spectrum of severity, with cases ranging from the extremely mild to those of perinatal mortality. Typical features include bone fragility; short stature; long bone deformity and persistent blue sclera(2). Although currently there is no cure for OI, with the input of a multidisciplinar...